Jasmine Rowe | AIChE

Jasmine Rowe

Citation name

Rowe, J.


Bristol-Myers Squibb





Jasmine Rowe is a Director in Oral Formulation Sciences at Merck, where she is responsible for drug product development for the advancement of Merck’s oral small-molecule pipeline. Within her role, she is also leading systemic efforts to advance pediatric formulation development and amorphous solid dispersion technology development. Prior to Merck, she supported drug product development at Bristol Myers Squibb for ~10 years, holding roles in Oral Drug Product Development and Engineering Technologies, which focused on progressing the implementation of small-scale tools and models to drive the pipeline. She holds a B.S. and Ph.D. in Chemical Engineering from the University of Arizona and the University of Texas at Austin, respectively.

Sessions chaired or co-chaired

Application of Quality By Design in Drug Product Process Development I
2014 AIChE Annual Meeting (ISBN: 978-0-8169-1086-1)
Continuous Processing in Drug Product
2022 Annual Meeting (ISBN: 978-0-8169-1118-9)
Continuous Processing: Next Generation Advancements
2023 AIChE Annual Meeting (ISBN: 978-0-8169-1120-2)
Facilities of the Future (Invited Talks)
2023 AIChE Annual Meeting (ISBN: 978-0-8169-1120-2)


Associated proceedings 

2014 AIChE Annual Meeting
2016 AIChE Annual Meeting
2013 AIChE Annual Meeting
2018 AIChE Annual Meeting
2022 Annual Meeting
2023 AIChE Annual Meeting